1 Department of Pediatrics, Pennsylvania State University Children's Hospital, Milton S. Hershey Medical Center, Hershey, PA
2 Department of Pediatrics, Children's Hospital of New Mexico, University of New Mexico School of Medicine, Albuquerque, NM
Objectives. To test the cortisol response to adrenocorticotrophic hormone (ACTH) in a population of very low birth weight newborns at the end of the first week of life, and to evaluate the relationship of this response to the subsequent development of bronchopulmonary dysplasia and to the total length of oxygen dependence.
Methods. Appropriate for gestational age newborns <1500 g birth weight were enrolled prospectively. Response to ACTH stimulation was tested on days 5, 6, or 7. Baseline cortisol, stimulated cortisol, and magnitude of response were compared between babies who developed bronchopulmonary dysplasia (BPD), defined as oxygen dependence at 28 days, and those who recovered without BPD.
Results. In this population, the cortisol response to ACTH increased with increasing birth weight (P < .001). Using birth weight as a cofactor, analysis of variance showed that patients who developed BPD (n = 34, BW 974 ± 192 g, mean ± S.D.) had significantly reduced responses to ACTH at 5 to 7 days of age compared to those who recovered (n = 25, BW 1251 ± 194 g), P = .006. Additionally, 84% of patients who recovered without BPD, but only 26% of BPD patients, achieved a prospectively defined positive cortisol response to ACTH (
9 µg/dL; P < .005). Supplemental oxygen was discontinued at a younger postconceptional age in babies with a positive cortisol response to ACTH (P < .01) and fewer of those babies were on supplemental oxygen at 36-week postconceptional age (P < .01).
Conclusions. At the end of the first week of life, infants who subsequently developed BPD and prolonged oxygen dependence had significantly lower cortisol secretion in response to ACTH than infants who recovered without BPD. We speculate that these babies may be unable to secrete adequate amounts of cortisol in a setting of increased stress, leaving them vulnerable to continuing lung injury.
Submitted on February 28, 1994
This article has been cited by other articles:
![]() |
S. W. Aucott, K. L. Watterberg, M. L. Shaffer, P. K. Donohue, and for the PROPHET Study Group Do Cortisol Concentrations Predict Short-Term Outcomes in Extremely Low Birth Weight Infants? Pediatrics, October 1, 2008; 122(4): 775 - 781. [Abstract] [Full Text] [PDF] |
||||
![]() |
K J Rademaker, L S de Vries, C S P M Uiterwaal, F Groenendaal, D E Grobbee, and F van Bel Postnatal hydrocortisone treatment for chronic lung disease in the preterm newborn and long-term neurodevelopmental follow-up Arch. Dis. Child. Fetal Neonatal Ed., January 1, 2008; 93(1): F58 - F63. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Watterberg, J. S. Gerdes, C. H. Cole, S. W. Aucott, E. H. Thilo, M. C. Mammel, R. J. Couser, J. S. Garland, H. J. Rozycki, C. L. Leach, et al. Prophylaxis of Early Adrenal Insufficiency to Prevent Bronchopulmonary Dysplasia: A Multicenter Trial Pediatrics, December 1, 2004; 114(6): 1649 - 1657. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Parikh, R. G. Locke, A. Chidekel, K. H. Leef, J. Emberger, D. A. Paul, and J. L. Stefano Effect of Inhaled Corticosteroids on Markers of Pulmonary Inflammation and Lung Maturation in Preterm Infants With Evolving Chronic Lung Disease J Am Osteopath Assoc, March 1, 2004; 104(3): 114 - 120. [Abstract] [Full Text] [PDF] |
||||
![]() |
P C Ng, C H Lee, C W K Lam, K C Ma, I H S Chan, E Wong, and T F Fok Early pituitary-adrenal response and respiratory outcomes in preterm infants Arch. Dis. Child. Fetal Neonatal Ed., March 1, 2004; 89(2): F127 - F130. [Abstract] [Full Text] [PDF] |
||||
![]() |
K Schwarz, R Thwaites, A Minford, C Day, and G Butler Congenital adrenal hypoplasia presenting as a chronic respiratory condition Arch. Dis. Child., March 1, 2003; 88(3): 261 - 262. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kajantie, L. Dunkel, U. Turpeinen, U.-H. Stenman, P. J. Wood, M. Nuutila, and S. Andersson Placental 11{beta}-Hydroxysteroid Dehydrogenase-2 and Fetal Cortisol/Cortisone Shuttle in Small Preterm Infants J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 493 - 500. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. Ng, C. W. K. Lam, C. H. Lee, K. C. Ma, T. F. Fok, I. H. S. Chan, and E. Wong Reference Ranges and Factors Affecting the Human Corticotropin-Releasing Hormone Test in Preterm, Very Low Birth Weight Infants J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4621 - 4628. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. JOBE and E. BANCALARI Bronchopulmonary Dysplasia Am. J. Respir. Crit. Care Med., June 1, 2001; 163(7): 1723 - 1729. [Full Text] [PDF] |
||||
![]() |
B. A. Banks, N. Stouffer, A. Cnaan, Y. Ning, J. D. Merrill, R. A. Ballard, P. L. Ballard, and the North American Thyrotropin-Releasing Hormone T Association of Plasma Cortisol and Chronic Lung Disease in Preterm Infants Pediatrics, March 1, 2001; 107(3): 494 - 498. [Abstract] [Full Text] |
||||
![]() |
P C Ng, C W K Lam, T F Fok, C H Lee, K C Ma, I H S Chan, and E Wong Refractory hypotension in preterm infants with adrenocortical insufficiency Arch. Dis. Child. Fetal Neonatal Ed., March 1, 2001; 84(2): 122F - 124. [Abstract] [Full Text] |
||||
![]() |
G. P. Chrousos Adrenal Suppression Versus Clinical Glucocorticoid Deficiency in the Premature Infant: No Simple Answers J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 473 - 474. [Full Text] |
||||
![]() |
A. R. Stark, W. A. Carlo, J. E. Tyson, L.-A. Papile, L. L. Wright, S. Shankaran, E. F. Donovan, W. Oh, C. R. Bauer, S. Saha, et al. Adverse Effects of Early Dexamethasone Treatment in Extremely-Low-Birth-Weight Infants N. Engl. J. Med., January 11, 2001; 344(2): 95 - 101. [Abstract] [Full Text] [PDF] |
||||
![]() |
P C Ng The fetal and neonatal hypothalamic-pituitary-adrenal axis Arch. Dis. Child. Fetal Neonatal Ed., May 1, 2000; 82(3): 250F - 254. [Full Text] |
||||
![]() |
R. A. Sinkin, H. S. Dweck, M. J. Horgan, K. J. Gallaher, C. Cox, W. M. Maniscalco, P. R. Chess, C. T. D'Angio, R. Guillet, J. W. Kendig, et al. Early Dexamethasone---Attempting To Prevent Chronic Lung Disease Pediatrics, March 1, 2000; 105(3): 542 - 548. [Abstract] [Full Text] |
||||
![]() |
K. L. Watterberg, S. M. Scott, C. Backstrom, K. L. Gifford, and K. L. Cook Links Between Early Adrenal Function and Respiratory Outcome in Preterm Infants: Airway Inflammation and Patent Ductus Arteriosus Pediatrics, February 1, 2000; 105(2): 320 - 324. [Abstract] [Full Text] |
||||
![]() |
K. L. Watterberg, J. S. Gerdes, K. L. Gifford, and H.-M. Lin Prophylaxis Against Early Adrenal Insufficiency to Prevent Chronic Lung Disease in Premature Infants Pediatrics, December 1, 1999; 104(6): 1258 - 1263. [Abstract] [Full Text] |
||||
![]() |
D. A. Paul, K. H. Leef, J. L. Stefano, and L. Bartoshesky Low Serum Thyroxine on Initial Newborn Screening Is Associated With Intraventricular Hemorrhage and Death in Very Low Birth Weight Infants Pediatrics, May 1, 1998; 101(5): 903 - 907. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. F. Yeh, Y. J. Lin, W. S. Hsieh, H. C. Lin, C. H. Lin, J. Y. Chen, H. A. Kao, and C. H. Chien Early Postnatal Dexamethasone Therapy for the Prevention of Chronic Lung Disease in Preterm Infants With Respiratory Distress Syndrome: A Multicenter Clinical Trial Pediatrics, October 1, 1997; 100(4): e3 - e3. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. Jett, M. H. Samuels, P. A. McDaniel, G. I. Benda, S. H. LaFranchi, J. W. Reynolds, and C. E. Hanna Variability of Plasma Cortisol Levels in Extremely Low Birth Weight Infants J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 2921 - 2925. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Watterberg, S. M. Scott, and R. L. Naeye Chorioamnionitis, Cortisol, and Acute Lung Disease in Very Low Birth Weight Infants Pediatrics, February 1, 1997; 99(2): e6 - e6. [Abstract] [Full Text] [PDF] |
||||